LRCX — Equity Research

Executive Summary

Rating: SELL | LRCX

I would put my rating as a Sell because Lam Research already trades at 46.5x forward P/E and 65.1x EV/EBITDA, so the market is paying for a strong cycle that still has to prove it can sustain itself. The company is executing well — revenue reached $5,841.5M in Q1 2026 and TTM operating margin held at 35.0% — but that quality is already reflected in the price. I would move toward Hold if quarterly revenue stays above $5.8B, meaning the current run rate is holding, and operating margin remains above 30.0%, which would show pricing power is still intact.

Company Profile

Lam Research Corporation, incorporated in 1980 and headquartered in Fremont, California, supplies wafer fabrication equipment and services to semiconductor makers. Its revenue comes from deposition, etch, and clean systems, plus customer support services such as spares, upgrades, refurbished tools, and equipment-intelligence software that improve uptime and throughput. The company also serves advanced packaging, wafer-level packaging, CMOS image sensors, and MEMS markets. It operates a global network of facilities across Asia, Europe, and the United States, with service engineers in the U.S., China, Europe, India, Japan, Korea, Southeast Asia, and Taiwan. The business was materially expanded by the June 2012 acquisition of Novellus Systems, which broadened its deposition and customer-support portfolio.

Economic Moat

Business Model

The core moat is installed-base lock-in: once a semiconductor manufacturer qualifies a Lam tool for a specific node, it typically keeps that supplier for that application because requalifying new wafer fabrication equipment is costly and disruptive, according to their SEC 10-K. That switching friction is hardest to overcome in deposition, etch, and clean, where Lam’s tools sit inside multi-step production flows. I also see a second advantage in the company’s process-specific learning loop from a broad installed base, which supports upgrades, spares, and equipment-intelligence services.

Business & Operating Risks

The main disclosed risk is customer concentration and the cyclicality of wafer-fab spending. Lam’s business depends on a relatively small number of large semiconductor manufacturers, so a pause in capex can move revenue quickly even when the installed base remains intact. That does not break the moat, but it does mean the moat is tested by timing: the tools are sticky, yet order flow can still swing with the industry cycle.

Management Discussion & Analysis

Management is still prioritizing shareholder returns over balance-sheet defense. In FY2024, Lam spent $2.8B on treasury stock purchases and $1B on dividends, while capital expenditures were only $397M, which tells me the company is not chasing a major capacity buildout. Operating cash flow was $4.7B in FY2024, so the payout program is funded, but the message is clear: management is leaning on the installed base and cash generation rather than trying to buy growth with heavy reinvestment. R&D rose to $1.9B, or 12.8% of revenue, which supports the moat because the company is still investing in the process technology that keeps customers tied to its platform.

Recent Earnings

The latest quarter shows the moat is still translating into pricing power and volume. Revenue rose to $5,841.5M in Q1 2026 from $4,720.2M in Q1 2025, while EBITDA increased to $2,167.2M from $1,679.3M and net income reached $1,825.5M from $1,330.7M. That is not just top-line growth; it shows the installed base and product mix are still producing strong operating leverage, even if the path is uneven quarter to quarter.

Financial Analysis

Growth

LRCX — Financial Growth (Quarterly, USD Mil)

Source: Yahoo Finance — Quarterly Financial Statements

Revenue grew from $4,720.2M in Q1 2025 to $5,841.5M in Q1 2026, a 23.7% increase. EBITDA rose faster than sales over the same period, which tells me Lam is not only growing but also converting that growth into better operating leverage. The one-quarter flattening in late 2025 matters less than the year-over-year trend, because it looks like a cyclical pause rather than a break in demand.

Profitability

LRCX — Profitability (TTM)

Source: Yahoo Finance — Trailing Twelve Months (TTM)

TTM operating margin was 35.0%, net margin was 30.9%, ROA was 22.8%, and ROE was 66.8%. That is a high-quality margin profile for a capital equipment company, and it tells me Lam is already well past the stage where investors should focus on breakeven or turnaround metrics. The key point is that profitability is strong enough to support the valuation, but not so exceptional that it removes cyclicality from the stock.

Valuation

LRCX — Valuation Multiples

Source: Yahoo Finance

Lam trades at 23.6x EV/Revenue, 65.1x EV/EBITDA, 46.5x forward P/E, and 0.9% FCF yield. Those are demanding multiples for a business that is still tied to semiconductor capex, even if the earnings quality is strong. I would put fair value in a broad $220–$480 range, which is the analyst target span, but my own center of gravity sits below the $340.6 mean because I weight the low cash yield and cyclicality more heavily than the consensus appears to. Forward EPS is $8.0, and that looks rich relative to peers on a growth-adjusted basis only if the current revenue run rate holds; if it slips, the multiple leaves little cushion.

Leverage

LRCX — Leverage & Coverage (Quarterly)

Source: Yahoo Finance — Quarterly Financial Statements

Debt/equity was 35.3%, current ratio was 2.5x, and total debt was $3,734.5M. Operating cash flow of $6,954.6M and levered free cash flow of $4,352.3M show the balance sheet is supported by real cash generation, not just accounting earnings. I would not call this a refinancing story, though, because the data do not show a debt maturity schedule; what matters is that Lam has enough liquidity to absorb a downturn without forcing a change in capital allocation.

Comparable Analysis

Growth

Source: Yahoo Finance

LRCX’s revenue growth was 23.8% TTM, versus 11.5% for KLAC and 11.4% for AMAT. That is the clearest growth edge in the group, and it explains why Lam deserves some valuation premium even before you look at margins. The catch is that the market is not giving Lam a growth multiple for free: KLAC still trades richer on EV/Revenue at 26.9x versus Lam’s 23.6x, so the premium is really about the mix of growth and perceived durability.

Valuation

Source: Yahoo Finance

LRCX’s 23.6x EV/Revenue and 46.5x forward P/E compare with KLAC at 26.9x and 48.5x, and AMAT at 17.5x and 36.1x. On a one-year basis, a 1 investment would be worth 4.50 in LRCX, 3.75 in KLAC, and 3.75 in AMAT, so Lam has already outperformed the group by a wide margin. That makes the stock look expensive on the surface, but the stronger growth and better cash conversion mean the premium is tied to execution rather than pure sentiment.

Profitability

Source: Yahoo Finance

LRCX’s 35.0% operating margin and 30.9% net margin sit below KLAC’s 41.2% and 35.7%, but above AMAT’s 31.9% and 29.3%. ROE was 66.8% for Lam, versus 95.0% for KLAC and 39.7% for AMAT, so Lam is not the most efficient capital allocator in the group. Even so, the margin profile is strong enough that the valuation debate is about how much growth investors should pay for, not whether the business is profitable enough to justify a premium at all.

Leverage

Source: Yahoo Finance

Lam’s debt/equity of 35.3% is far below KLAC’s 105.4% and close to AMAT’s 30.4%, while current ratio at 2.5x matches AMAT and trails KLAC’s 3.0x. That balance-sheet position matters because it gives Lam more flexibility than KLAC if the cycle softens, which helps explain why Lam can trade at a premium without looking reckless. In other words, the market is paying for growth and a cleaner balance sheet together, not just for one or the other.

Conclusion

I would put my rating as a Sell because the stock already prices in a lot of good news: 46.5x forward P/E, 65.1x EV/EBITDA, and only a 0.9% FCF yield leave little margin for error if semiconductor spending cools. The bull case is straightforward. If quarterly revenue stays above $5.8B, meaning the current demand run rate is holding, and operating margin remains above 30.0%, meaning pricing power is still intact, then I would be more open to a Hold because the earnings base would be proving itself through the cycle. If forward EPS also moves into the high-$8s, the valuation would start to look more like a justified growth premium than a full price for perfection.

The bear case is just as clear. If revenue falls back below $5.3B, roughly the late-2025 level that showed the recovery was still uneven, or if operating margin slips under 30.0%, meaning profitability is no longer holding through the cycle, then I would move from Sell toward a more negative stance because the current multiple would be unsupported. I would also watch whether free cash flow stays near $4.4B while buybacks and dividends remain heavy; if cash generation stops compounding, the capital-return story becomes less persuasive.

Weighing both sides, I think the market is still ahead of the fundamentals rather than behind them. Lam has the installed-base moat and the cash flow to keep compounding, but the stock already discounts a very strong outcome, so I need more evidence before I would turn constructive.

What’s your take? I rated LRCX (LRCX) SELL above — but the goal here is to get this right, not just to publish an opinion. What would you add to this analysis, or which risk or catalyst do you think I’m under- or over-weighting? Tell me in the comments.

Data sourced from Yahoo Finance. Not investment advice.